国家神经系统疾病临床医学研究中心数据管理与共享系统
Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Persistence with Antihypertensive Agents for 12 Months After Ischemic Stroke Reduces the Rates of Death and Dependency
第一作者：Jie Xu,Chunxue Wang
通讯作者：Yongjun Wang
基本信息
- 负责人：Jie Xu,Chunxue Wang
- 数据来源： CNSR-I
- 论文编号：CNSR120150025
- 发表时间：2012-12-26
2012-12-26
已发表文章
发表杂志：CNS Neuroscience & Therapeutics
发表类型: Original Contributions
影响因子(IF): 5.243
PMID: 23279879 Pubmed原文链接 全文下载
主要研究背景及目的
High adherence to antihypertensive therapy, and the associated blood pressure control, reduces the risk of initial stroke when used as primary prevention [1–3]. Kettani et al. [1] found that patients with high adherence to antihypertensive therapy (＞＝80% calcu-lated using the medication possession ratio) had a significantly lower risk of cerebrovascular disease, compared with patients with lower adherence. However, to our knowledge, the relationship between adherence to antihypertensive therapy after stroke and clinical outcomes has not been studied. The aim of this study was to assess the relationship between persistence with antihyperten-sive therapy after ischemic stroke and rates of death and depen-dency in patients with hypertension.